Share This! Tweet This! Print Page

Adolescent and Young Adult (AYA) Clinical Trials



A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Protocol Summary


A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating With Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864) in Patients With Intermediate Risk (IR) Rhabdomyosarcoma (RMS)

Protocol Summary


Current sub-studies: A, C2, E, F, G, J, K1, K2, L, M, S2, T, V, Z1E, Z1G, Z1H, Z1I

Molecular Analysis for Therapy Choice (MATCH)

Protocol Summary